ACTA1 Monoclonal Antibody
-
中文名稱:ACTA1鼠單克隆抗體
-
貨號(hào):CSB-MA158957
-
規(guī)格:¥2024
-
其他:
產(chǎn)品詳情
-
產(chǎn)品描述:CUSABIO貨號(hào):CSB-MA158957 ACTA1單克隆抗體是針對(duì)α-骨骼肌肌動(dòng)蛋白(ACTA1)研發(fā)的高特異性科研試劑,適用于人類、小鼠及大鼠樣本的肌肉生物學(xué)研究。作為肌動(dòng)蛋白家族核心成員,ACTA1在骨骼肌纖維的收縮功能和細(xì)胞骨架動(dòng)態(tài)調(diào)控中發(fā)揮關(guān)鍵作用,其表達(dá)異常與先天性肌病、肌營(yíng)養(yǎng)不良癥等骨骼肌病理機(jī)制密切相關(guān)。該抗體經(jīng)ELISA、免疫印跡(WB)和免疫沉淀(IP)多平臺(tái)驗(yàn)證,具備精準(zhǔn)識(shí)別ACTA1蛋白抗原表位的能力,適用于肌肉組織蛋白互作網(wǎng)絡(luò)解析、肌細(xì)胞分化機(jī)制探索及骨骼肌疾病模型構(gòu)建等基礎(chǔ)研究。產(chǎn)品采用高效免疫原設(shè)計(jì)確保高親和力結(jié)合,為肌肉發(fā)育調(diào)控、運(yùn)動(dòng)系統(tǒng)疾病分子機(jī)理研究提供可靠工具,廣泛應(yīng)用于細(xì)胞生物學(xué)、運(yùn)動(dòng)醫(yī)學(xué)及病理生理學(xué)等領(lǐng)域的蛋白質(zhì)功能研究。
-
別名:ACTA antibody, ACTA1 antibody, ACTC antibody, ACTC1 antibody, Actin alpha cardiac muscle antibody, ACTS antibody, Alpha actin 1 antibody, Cardiac muscle alpha actin 1 antibody, Skeletal muscle alpha actin 1 antibody
-
宿主:Mouse
-
反應(yīng)種屬:Human,Mouse,Rat
-
免疫原:
-
免疫原種屬:Homo sapiens (Human)
-
克隆類型:Monoclonal
-
純化方式:Antigen Affinity Purified
-
克隆號(hào):17F5
-
濃度:It differs from different batches. Please contact us to confirm it.
-
產(chǎn)品提供形式:Mouse IgG1 in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
-
應(yīng)用范圍:ELISA,WB,IP
-
推薦稀釋比:
Application Recommended Dilution WB 1:500-1:5000 IP 1:200-1:2000 -
Protocols:
-
儲(chǔ)存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Most popular with customers
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-















